Though the healthcare sector’s headline deal values may look healthy enough, policy upheavals in the US and ongoing fundraising pain may be weakening its underlying condition.

Whether there are more or fewer emerging managers vis-à-vis consolidations will depend greatly on when sustainable levels of fundraising return.

The US administration’s One Big Beautiful Bill Act is causing a raft of headaches for PE managers and LPs.